These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 2636666)
41. Effect of L-carnitine on ethanol and acetate plasma levels after oral administration of ethanol in humans. Adamo S; Siliprandi N; Dl Lisa F; Carrara M; Azzurro M; Sartori G; Vita G; Ghidini O Alcohol Clin Exp Res; 1988 Oct; 12(5):653-4. PubMed ID: 3067610 [TBL] [Abstract][Full Text] [Related]
42. Influence of acetate and bicarbonate dialysate on acyl carnitine in pyelonephritis. Jackson JM Ann Clin Biochem; 1999 Nov; 36 ( Pt 6)():786-8. PubMed ID: 10586325 [No Abstract] [Full Text] [Related]
43. L-Carnitine in dialysis, more than a commercial affair. Rodríguez-Benítez P; Pérez-García R; Arenas J; Valderrábano F Nephrol Dial Transplant; 2000 Sep; 15(9):1477-8. PubMed ID: 10978418 [No Abstract] [Full Text] [Related]
44. L-carnitine for anemia in hemodialysis patients: a last resort. Yee J Clin J Am Soc Nephrol; 2012 Nov; 7(11):1746-8. PubMed ID: 23085730 [No Abstract] [Full Text] [Related]
45. [Rapid gas chromatographic method for determination of acetate in human plasma and hemodialysis baths (author's transl)]. Desch G; Descomps B Clin Chim Acta; 1977 Apr; 76(2):193-204. PubMed ID: 862194 [TBL] [Abstract][Full Text] [Related]
46. The pharmacology of carnitine. Bahl JJ; Bressler R Annu Rev Pharmacol Toxicol; 1987; 27():257-77. PubMed ID: 3555318 [No Abstract] [Full Text] [Related]
47. Blood chemical continuous monitoring system for hemodialysis. Kabei N; Machiyama E; Yamada A; Kikuchi M; Sakurai Y Trans Am Soc Artif Intern Organs; 1978; 24():468-70. PubMed ID: 716041 [No Abstract] [Full Text] [Related]
48. Carnitine supplementation in uremia. Fürst P; Glöggler A; Rössle C Adv Exp Med Biol; 1989; 260():69-77. PubMed ID: 2696372 [No Abstract] [Full Text] [Related]
56. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis. Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A Kidney Int Suppl; 1989 Nov; 27():S247-55. PubMed ID: 2636666 [No Abstract] [Full Text] [Related]
57. Effect of dialysate composition on the lipid response to L-carnitine supplementation. Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997 [TBL] [Abstract][Full Text] [Related]
58. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668 [TBL] [Abstract][Full Text] [Related]
59. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis. Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873 [No Abstract] [Full Text] [Related]
60. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children. Glöggler A; Bulla M; Fürst P Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]